title: Factors influencing the outcome of balloon aortic valvuloplasty in the elderly.
abstract: This study describes the short- and long-term outcome of 44 consecutive percutaneous balloon aortic valvuloplasty procedures performed in 42 elderly patients (age 77.8 +/- 7 years) with calcific aortic stenosis. The initial success rate was 95%, with the peak aortic valve pressure gradient declining from a mean of 82 +/- 32 mm Hg to 44 +/- 23 mm Hg and aortic valve area increasing from a mean of 0.59 +/- 0.15 cm2 to 0.83 +/- 0.40 cm2. One procedure-related death occurred and an additional three patients died less than or equal to 30 days after balloon aortic valvuloplasty. These patients all had New York Heart Association (NYHA) class IV heart failure symptoms prior to the procedure and their mean left ventricular ejection fraction (LVEF) (28 +/- 7%) was lower than that of hospital survivors (52 +/- 13%) (as was their ratio of left ventricular [LV] wall thickness-to-cavity ratio [0.50 +/- 0.10 versus 0.70 +/- 0.15]). At the time of hospital discharge after valvuloplasty, 76% of patients were asymptomatic or markedly improved (NYHA class I or II). After a mean follow-up of 15.5 months (range 2 to 26 months), however, 10 patients had died and 15 had undergone aortic valve replacement for recurrence of NYHA class III or IV symptoms. The adjusted 1- and 2-year survivals were 0.68 and 0.62, respectively, and adjusted 2-year event-free survival was 0.25. Proportional hazard regression analysis indicated that LVEF less than 40% was the only variable affecting survival (p less than 0.01) and was a possible indicator of event-free survival (p = 0.07).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, Baylor College of Medicine, Houston, TX.
authors.forename: A R
authors.initials: AR
authors.lastname: Rodriguez
authors.forename: N S
authors.initials: NS
authors.lastname: Kleiman
authors.forename: S T
authors.initials: ST
authors.lastname: Minor
authors.forename: W A
authors.initials: WA
authors.lastname: Zoghbi
authors.forename: M S
authors.initials: MS
authors.lastname: West
authors.forename: C A
authors.initials: CA
authors.lastname: DeFelice
authors.forename: D A
authors.initials: DA
authors.lastname: Samuels
authors.forename: R
authors.initials: R
authors.lastname: Cashion
authors.forename: J D
authors.initials: JD
authors.lastname: Pickett
authors.forename: J M
authors.initials: JM
authors.lastname: Lewis
mesh_terms: D000368:Aged; D001024:Aortic Valve Stenosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D002404:Catheterization; D006350:Heart Valve Prosthesis; D006439:Hemodynamics; D006760:Hospitalization; D006801:Humans; D011379:Prognosis; D012008:Recurrence; D012086:Reoperation; D016019:Survival Analysis